These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 17110327)

  • 41. Dynasore inhibits removal of wild-type and DeltaF508 cystic fibrosis transmembrane conductance regulator (CFTR) from the plasma membrane.
    Young A; Gentzsch M; Abban CY; Jia Y; Meneses PI; Bridges RJ; Bradbury NA
    Biochem J; 2009 Jul; 421(3):377-85. PubMed ID: 19442237
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Trafficking of immature DeltaF508-CFTR to the plasma membrane and its detection by biotinylation.
    Luo Y; McDonald K; Hanrahan JW
    Biochem J; 2009 Apr; 419(1):211-9, 2 p following 219. PubMed ID: 19053947
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Analysis of CFTR folding and degradation in transiently transfected cells.
    Grove DE; Rosser MF; Watkins RL; Cyr DM
    Methods Mol Biol; 2011; 741():219-32. PubMed ID: 21594788
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Direct interaction of a small-molecule modulator with G551D-CFTR, a cystic fibrosis-causing mutation associated with severe disease.
    Pasyk S; Li C; Ramjeesingh M; Bear CE
    Biochem J; 2009 Feb; 418(1):185-90. PubMed ID: 18945216
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Most F508del-CFTR is targeted to degradation at an early folding checkpoint and independently of calnexin.
    Farinha CM; Amaral MD
    Mol Cell Biol; 2005 Jun; 25(12):5242-52. PubMed ID: 15923638
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Reticulocyte lysate as a model system to study endoplasmic reticulum membrane protein degradation.
    Carlson E; Bays N; David L; Skach WR
    Methods Mol Biol; 2005; 301():185-205. PubMed ID: 15917633
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A chaperone trap contributes to the onset of cystic fibrosis.
    Coppinger JA; Hutt DM; Razvi A; Koulov AV; Pankow S; Yates JR; Balch WE
    PLoS One; 2012; 7(5):e37682. PubMed ID: 22701530
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Correcting the F508del-CFTR variant by modulating eukaryotic translation initiation factor 3-mediated translation initiation.
    Hutt DM; Loguercio S; Roth DM; Su AI; Balch WE
    J Biol Chem; 2018 Aug; 293(35):13477-13495. PubMed ID: 30006345
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Endoplasmic Reticulum-Targeted Subunit Toxins Provide a New Approach to Rescue Misfolded Mutant Proteins and Revert Cell Models of Genetic Diseases.
    Adnan H; Zhang Z; Park HJ; Tailor C; Che C; Kamani M; Spitalny G; Binnington B; Lingwood C
    PLoS One; 2016; 11(12):e0166948. PubMed ID: 27935997
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Selective Binding of HSC70 and its Co-Chaperones to Structural Hotspots on CFTR.
    Baaklini I; Gonçalves CC; Lukacs GL; Young JC
    Sci Rep; 2020 Mar; 10(1):4176. PubMed ID: 32144307
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Correctors enhance maturation of DeltaF508 CFTR by promoting interactions between the two halves of the molecule.
    Loo TW; Bartlett MC; Clarke DM
    Biochemistry; 2009 Oct; 48(41):9882-90. PubMed ID: 19761259
    [TBL] [Abstract][Full Text] [Related]  

  • 52. CFTR folding and maturation in cells.
    Benharouga M; Sharma M; Lukacs GL
    Methods Mol Med; 2002; 70():229-43. PubMed ID: 11917526
    [No Abstract]   [Full Text] [Related]  

  • 53. Expression of cystic fibrosis transmembrane conductance regulator in ganglion cells of the hearts.
    Pan P; Guo Y; Gu J
    Neurosci Lett; 2008 Aug; 441(1):35-8. PubMed ID: 18584958
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Localization of the BiP molecular chaperone with respect to endoplasmic reticulum foci containing the cystic fibrosis transmembrane conductance regulator in yeast.
    Sullivan ML; Youker RT; Watkins SC; Brodsky JL
    J Histochem Cytochem; 2003 Apr; 51(4):545-8. PubMed ID: 12642634
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mechanism of direct bicarbonate transport by the CFTR anion channel.
    Tang L; Fatehi M; Linsdell P
    J Cyst Fibros; 2009 Mar; 8(2):115-21. PubMed ID: 19019741
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Destabilization of the transmembrane domain induces misfolding in a phenotypic mutant of cystic fibrosis transmembrane conductance regulator.
    Choi MY; Partridge AW; Daniels C; Du K; Lukacs GL; Deber CM
    J Biol Chem; 2005 Feb; 280(6):4968-74. PubMed ID: 15537638
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Modulating the folding of P-glycoprotein and cystic fibrosis transmembrane conductance regulator truncation mutants with pharmacological chaperones.
    Wang Y; Loo TW; Bartlett MC; Clarke DM
    Mol Pharmacol; 2007 Mar; 71(3):751-8. PubMed ID: 17132688
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Misassembled mutant DeltaF508 CFTR in the distal secretory pathway alters cellular lipid trafficking.
    Gentzsch M; Choudhury A; Chang XB; Pagano RE; Riordan JR
    J Cell Sci; 2007 Feb; 120(Pt 3):447-55. PubMed ID: 17213331
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A novel HSP90 chaperone complex regulates intracellular vesicle transport.
    Lotz GP; Brychzy A; Heinz S; Obermann WM
    J Cell Sci; 2008 Mar; 121(Pt 5):717-23. PubMed ID: 18270269
    [TBL] [Abstract][Full Text] [Related]  

  • 60. CFTR expression and ER-associated degradation in yeast.
    Zhang Y; Michaelis S; Brodsky JL
    Methods Mol Med; 2002; 70():257-65. PubMed ID: 11917528
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.